首页> 外文会议>Proceedings of the 6th CCTCNM-KSP-JSP joint symposium on pharmacognosy >Effects of p-glucosidase hydrolyzed products of harpagide and harpagoside on cyclooxygenase-2 (COX-2) in vitro
【24h】

Effects of p-glucosidase hydrolyzed products of harpagide and harpagoside on cyclooxygenase-2 (COX-2) in vitro

机译:Harpagide和Harpagoside的p-葡萄糖苷酶水解产物对体外环氧合酶2(COX-2)的影响

获取原文
获取原文并翻译 | 示例

摘要

Harpagide (1) and harpagoside (2) are two iridoid glycosides existing in many medicinal plants. Although they are believed to be the main bioactive compounds related to the anti-inflammatory efficacy of these plants, the mechanisms of their antiinflammatory activities remain unclear. The results of our present study showed that 1 and 2 had no effects on inhibitions of cyclooxygenase (COX)-1/2 enzyme activity, tumor necrosis factor-a (TNF-a) release, and nitric oxide (NO) production in vitro. However, the hydrolyzed products of 1 and 2 with Pglucosidase treatment showed a significant inhibitory effect on COX-2 activity at 2.5-100 uM in a concentration-dependent manner. Our further study revealed that the hydrolyzed 2 product was structurally the same as the hydrolyzed 1 product (Hharpagide (3) ). The structure of 3 was 2(formylmethyl)-2,3,5-trihydroxy-5- methylcyclopentane carbaldehyde, with a backbone similar to prostaglandins and COX-2 inhibitors such as celecoxib. All of them have a pentatomic ring with two adjacent side chains. The result of molecular modeling and docking study showed that 3 could bind to the COX-2 active domain well through hydrophobic and hydrogen-bonding interactions, whereas 1 and 2 could not, implying that the hydrolysis of the glycosidic bond of 1 and 2 is a pre-requisite step for their COX-2 inhibitory activity.
机译:Harpagide(1)和harpagoside(2)是许多药用植物中存在的两种鸢尾类苷。尽管据信它们是与这些植物的抗炎功效有关的主要生物活性化合物,但其抗炎活性的机制仍不清楚。我们目前的研究结果表明1和2对体外环氧合酶(COX)-1/2酶活性,肿瘤坏死因子-a(TNF-a)释放和一氧化氮(NO)产生的抑制均无影响。然而,经葡糖苷酶处理的1和2的水解产物以浓度依赖的方式对2.5-100 uM的COX-2活性表现出显着的抑制作用。我们的进一步研究表明,水解2产物与水解1产物在结构上相同(Hharpagide(3))。 3的结构为2(甲酰基甲基)-2,3,5-三羟基-5-甲基环戊烷甲醛,骨架类似于前列腺素和塞来昔布等COX-2抑制剂。它们都有一个带有两个相邻侧链的五原子环。分子建模和对接研究的结果表明,3可以通过疏水和氢键相互作用很好地结合到COX-2活性域,而1和2则不能,这表明1和2的糖苷键的水解是抑制其COX-2活性的必要步骤。

著录项

  • 来源
  • 会议地点 Shenyang(CN)
  • 作者单位

    School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China;

    School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China;

    School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China;

    Murad Research Institute for Modernized Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;

    School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China;

    Institute of Chinese Materia Medica. Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China;

    School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China;

    School of Pharmacy, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生药学(天然药物学);
  • 关键词

    Harpagide; harpagoside; iridoids; anti-inflammation; p-glucosidase; COX-2 inhibitors;

    机译:哈帕吉特harpagoside;虹彩抗发炎;对-葡萄糖苷酶; COX-2抑制剂;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号